Literature DB >> 3699565

Gall stone disease without gall stones--bile acid and bile lipid metabolism after complete gall stone dissolution.

D C Ruppin, G M Murphy, R H Dowling.   

Abstract

Although bile acid and bile lipid metabolism have been studied in established cholelithiasis, little is known about them in patients destined to develop gall stones, but in whom the stones have not yet appeared (prestone gall stone disease). After confirmed complete gall stone dissolution and withdrawal of treatment, gall stones recur frequently. Before the stones reappear, these patients have 'poststone gall stone disease'. In 13 such patients we confirmed complete gall stone dissolution with two normal cholecystograms and in 11 of the 13 by normal ultrasonography, measured bile acid and bile lipid composition in fasting duodenal bile, bile acid synthesis from marker corrected three day faecal bile acid excretion, bile acid pool size using an abbreviated isotope dilution technique, 'steady-state' bile lipid secretion using a duodenal amino acid perfusion system and then calculated the enterohepatic cycling frequency of the bile acid pool and the relationship between pool size and body weight. The results confirm that after withdrawal of treatment the biliary cholesterol saturation index reverts to levels (1.6 +/- SEM 0.4) comparable with those before dissolution therapy first began (1.6 +/- 0.2; NS). The mean bile acid pool size in the 13 patients of 4.4 +/- 0.5 mmol was comparable with that in untreated gall stone patients. Pool size was significantly smaller in the nine non-obese patients (3.5 +/- 0.3), than in the four obese (6.0 +/- 0.8; p less than 0.05). It also correlated significantly with body weight (r = 0.72) and with %IBW (r = 0.79). The coefficients of variation for biliary bile acid, phospholipid and cholesterol secretion were high, but the mean hourly secretion rates were of the same order as those seen in untreated gall stone patients studied with the amino acid duodenal perfusion stimulus. These results provide a baseline for assessing the response to postdissolution treatment and may indicate metabolic events leading to gall stone formation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3699565      PMCID: PMC1433487          DOI: 10.1136/gut.27.5.559

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  45 in total

1.  Determination of sulfobromophthalein in serum.

Authors:  D SELIGSON; J MARINO; E DODSON
Journal:  Clin Chem       Date:  1957-10       Impact factor: 8.327

2.  Gallstone dissolution in man using chenodeoxycholic acid.

Authors:  G D Bell; B Whitney; R H Dowling
Journal:  Lancet       Date:  1972-12-09       Impact factor: 79.321

3.  Diminished bile acid pool size in patients with gallstones.

Authors:  Z R Vlahcevic; C C Bell; I Buhac; J T Farrar; L Swell
Journal:  Gastroenterology       Date:  1970-08       Impact factor: 22.682

4.  A physiological method for estimation of hepatic secretion of biliary lipids in man.

Authors:  S M Grundy; A L Metzger
Journal:  Gastroenterology       Date:  1972-06       Impact factor: 22.682

5.  Induced alterations in composition of bile of persons having cholelithiasis.

Authors:  J L Thistle; L J Schoenfield
Journal:  Gastroenterology       Date:  1971-10       Impact factor: 22.682

6.  The solubility of cholesterol in aqueous solutions of bile salts and lecithin.

Authors:  F G Hegardt; H Dam
Journal:  Z Ernahrungswiss       Date:  1971-04

7.  Significance of the liver in the production of lithogenic bile in man.

Authors:  Z R Vlahcevic; C Bell; L Swell
Journal:  Gastroenterology       Date:  1970-07       Impact factor: 22.682

8.  Prestone gallstone disease--is therapy safe?

Authors:  D M Small
Journal:  N Engl J Med       Date:  1971-01-28       Impact factor: 91.245

9.  Mucous substances and viscosity of normal and pathological human bile.

Authors:  I A Bouchier; S R Cooperband; B M el-Kodsi
Journal:  Gastroenterology       Date:  1965-10       Impact factor: 22.682

10.  Dissolution of cholesterol gallstones by chenodeoxycholic acid.

Authors:  R G Danzinger; A F Hofmann; L J Schoenfield; J L Thistle
Journal:  N Engl J Med       Date:  1972-01-06       Impact factor: 91.245

View more
  3 in total

1.  Gall stone recurrence and its prevention: the British/Belgian Gall Stone Study Group's post-dissolution trial.

Authors:  K A Hood; D Gleeson; D C Ruppin; R H Dowling
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

2.  Recurrence and re-recurrence of gall stones after medical dissolution: a longterm follow up.

Authors:  L D O'Donnell; K W Heaton
Journal:  Gut       Date:  1988-05       Impact factor: 23.059

3.  An experimental model for the combined medical and surgical treatment of gallstones.

Authors:  W G Moscovici; J O Marks; C K McSherry
Journal:  Surg Endosc       Date:  1988       Impact factor: 4.584

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.